Hepatic stellate cells and the reversal of fibrosis
暂无分享,去创建一个
[1] D. Brenner,et al. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype , 2003, Hepatology.
[2] D. Brenner,et al. Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis , 2001, Seminars in liver disease.
[3] M. Varela-Rey,et al. p38 MAPK mediates the regulation of alpha1(I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells(1). , 2002, FEBS letters.
[4] J. Fallowfield,et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. , 2004, Gastroenterology.
[5] V. Paradis,et al. Liver extracellular matrix in health and disease , 2003, The Journal of pathology.
[6] D. Rockey,et al. Dose‐dependent inhibition of hepatic fibrosis in mice by a TGF‐β soluble receptor: Implications for antifibrotic therapy , 2002, Hepatology.
[7] Kazuhiro Hanazaki,et al. Antiviral therapy for chronic hepatitis B: a review. , 2004, Current drug targets. Inflammation and allergy.
[8] Jozsef Dudas,et al. Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. , 2004, European journal of cell biology.
[9] Z. Kmieć,et al. Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.
[10] Liying Li,et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. , 2005, Gastroenterology.
[11] A. Czaja,et al. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. , 2004, Journal of hepatology.
[12] J. Jaffrezou,et al. p38 MAPK mediates the regulation of α1(I) procollagen mRNA levels by TNF‐α and TGF‐β in a cell line of rat hepatic stellate cells 1 , 2002 .
[13] M. Manns,et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. , 2002, Gastroenterology.
[14] T. Wynn. Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.
[15] G. Gores,et al. Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis , 2003, Hepatology.
[16] F. Oakley,et al. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis , 2005, Apoptosis.
[17] J. Iredale. Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.
[18] T. Wynn. Fibrotic disease and the T(H)1/T(H)2 paradigm. , 2004, Nature reviews. Immunology.
[19] S. Friedman,et al. Reversal of hepatic fibrosis — Fact or fantasy? , 2006, Hepatology.
[20] D. Brenner,et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. , 2003, Gastroenterology.
[21] T. Wynn. IL-13 effector functions. , 2003, Annual review of immunology.
[22] H. Bujard,et al. Conditional tetracycline‐regulated expression of TGF‐β1 in liver of transgenic mice leads to reversible intermediary fibrosis , 2003, Hepatology.
[23] John P. Iredale,et al. Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.
[24] D. Brenner,et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. , 2001, Journal of hepatology.
[25] G. Ramadori,et al. Transforming growth factor β and tumor necrosis factor α inhibit both apoptosis and proliferation of activated rat hepatic stellate cells , 1999 .
[26] M. Vidaud,et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. , 1999, Gastroenterology.
[27] Christopher J. Parsons,et al. Antifibrotic effects of a tissue inhibitor of metalloproteinase‐1 antibody on established liver fibrosis in rats , 2004, Hepatology.
[28] G. Ramadori,et al. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. , 1999, Hepatology.
[29] G. Ramadori,et al. Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. , 2005, European journal of cell biology.
[30] J. Iredale,et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. , 2001, Gastroenterology.
[31] R. Schwabe,et al. Anandamide induces necrosis in primary hepatic stellate cells , 2005, Hepatology.
[32] R. Sun,et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.